Thyrotoxicosis
Conditions
Interventions
None listed
Sponsors
Tottori university Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Uncontrolled Grave's disease Male and female aged 20 years or older at the time of consent acquisition Those who have been diagnosed as Graves' disease, subacute thyroiditis, or painless thyroiditis according to guidelines from the Japanese Thyroid Association 2.euthyroid patients Men and women aged 20 years or older at the time of consent acquisition Those with TSH and Free T4 within the reference range by treatment of Graves' disease, indolent thyroiditis, subacute thyroiditis 3. Normal control Men and women aged 20 years or older at the time of consent acquisition Those who have no history of thyroid disease TSH and Free T4 are within the reference range TRAb negative person
Exclusion criteria
Exclusion criteria: Patient diagnosed as sleep apnea with simple PSG Pregnant or lactating women Patients with respiratory disease Patients with heart disease Patients with cerebrovascular disease, dementia Patients with mental illness Others who judged that the research director is inappropriate as a patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change rate of total score of Pittsburgh Sleep Questionnaire (PSQI) before and 12,26 and 52 weeks after treatment in patients with thyrotoxicosis | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep quality, sleeping time, sleeping time, sleep efficiency, difficulty sleeping, use of sleeping agents, difficulty during daytime awakening, change rate of SF - 36 | — |
Countries
Japan
Contacts
Public ContactKazuhisa Matsumoto
Tottori university Hospital Division of Molecular Medicine and Therapeutics
Outcome results
None listed